No overdose data available.
Hypersensitivity.
Reduces the need for ophthalmic drugs containing glucocorticosteroids.
Headache, throat peeling, coughing, dry mouth.
Prevention and treatment of bronchial asthma in adults and children.
Prevents the degradation of fat cells and the separation of histamine, bradikinin, leukotrienes from them (including.h. slowly responding substance) and other biologically active substances. Most effective in preventive use.
Absorption through the mucous membrane of the eyes is negligible. System bioavailability is less than 0.1%. T1/2 - 5-10 minutes.
Keep out of the reach of children.
Shelf life of the drug Kropoz3 years.Do not apply after the expiration date indicated on the package.
| Aerosol is inhalation metered | 1 dose |
| mongrel mound | 5 mg |
in aerosol cylinders of 15 ml (150 doses), complete with an inhalation nozzle and a safety cap; in a cardboard box 1 cylinder.
Perhaps if the expected effect of therapy exceeds the potential risk to the fetus.
Inhalation. Adults, including elderly people, and children: 5–10 mg 4 times a day, in severe cases or at a high concentration of allergens - 5–10 mg to 8 times a day or 10–20 mg 4 times a day.
For the prevention of bronchospasm caused by physical stress or cold air, 10 mg per 10–15 min to the provoking factor.
